Usefulness of procalcitonin serum level for the diagnosis of bacteremia

被引:81
作者
Liaudat, S
Dayer, E
Praz, G
Bille, J
Troillet, N
机构
[1] Valais Hosp, Cent Inst, Div Infect Dis & Immunol, CH-1950 Sion, Switzerland
[2] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
关键词
D O I
10.1007/s100960100548
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The predictive value of procalcitonin serum levels to detect or rule out bacteremia was investigated prospectively in a case-control study with 200 hospitalized adults from whom blood samples were taken for culture. Fifty bacteremic patients (cases) had higher procalcitonin serum levels than the 150 controls with sterile blood cultures (11.7 vs. 0.7 ng/ml; P=0.0001), a difference that remained significant after controlling for potential confounders in multivariate analysis. At cut-off values of 0.5 and 0.2 ng/ml, the sensitivity of procalcitonin was 56 and 92%, and the specificity was 83 and 43%, respectively. These results yielded low positive (22 and 12%) and high negative predictive values (96 and 99%), reflecting primarily the low prevalence of bacteremia among patients who undergo blood cultures in hospitals (low pretest probability). Although caution is mandatory when using such markers at the individual level, procalcitonin, possibly together with other parameters, could nonetheless prove useful in future studies to rapidly rule out bacteremia.
引用
收藏
页码:524 / 527
页数:4
相关论文
共 20 条
[1]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[2]  
Al-Nawas Bilal, 1998, Clin Microbiol Infect, V4, P237
[3]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[4]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]   Prediction of microbial infection and mortality in medical patients with fever:: Plasma procalcitonin, neutrophilic elastase-α1-antitrypsin, and lactoferrin compared with clinical variables [J].
Bossink, AWJ ;
Groeneveld, ABJ ;
Thijs, LG .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :398-407
[6]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[7]   Adult patients with occult bacteremia discharged from the emergency department: Epidemiological and clinical characteristics [J].
Epstein, D ;
Raveh, D ;
Schlesinger, Y ;
Rudensky, B ;
Gottehrer, NP ;
Yinnon, AM .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (04) :559-565
[8]   Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections [J].
Gendrel, D ;
Raymond, J ;
Coste, J ;
Moulin, F ;
Lorrot, M ;
Guérin, S ;
Ravilly, S ;
Lefèvre, H ;
Royer, C ;
Lacombe, C ;
Palmer, P ;
Bohuon, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (10) :875-881
[9]   Measurement of procalcitonin levels in children with bacterial or viral meningitis [J].
Gendrel, D ;
Raymond, J ;
Assicot, M ;
Moulin, F ;
Iniguez, JL ;
Lebon, P ;
Bohuon, C .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1240-1242
[10]   Procalcitonin as a marker of bacterial infection [J].
Gendrel, D ;
Bohuon, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) :679-688